Evolution of cytokines/chemokines in cases with severe nosocomial pneumonia and distinct etiologies in mechanical ventilated patients.

D. Dmytriiev (Vinnitsya, Ukraine), K. Dmytriiev (Vinnitsya, Ukraine), O. Nazarchuk (Vinnitsya, Ukraine), Y. Babina (Vinnitsya, Ukraine), K. Dmytriieva (Vinnitsya, Ukraine)

Source: Virtual Congress 2021 – Acute paediatric respiratory infections
Session: Acute paediatric respiratory infections
Session type: E-poster
Number: 1968

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Dmytriiev (Vinnitsya, Ukraine), K. Dmytriiev (Vinnitsya, Ukraine), O. Nazarchuk (Vinnitsya, Ukraine), Y. Babina (Vinnitsya, Ukraine), K. Dmytriieva (Vinnitsya, Ukraine). Evolution of cytokines/chemokines in cases with severe nosocomial pneumonia and distinct etiologies in mechanical ventilated patients.. 1968

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients
Source: International Congress 2016 – Sepsis and ARDS: looking forward
Year: 2016


Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome
Source: Eur Respir J 2002; 20: 1483-1489
Year: 2002



is hypercapnia associated with severe forms of community-acquired pneumonia?
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007

Local and systemic cytokine profiles in patients with non-severe and severe community-acquired pneumonia
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012

Late-onset ventilator-associated pneumonia in patients with acute nervous system infections
Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track
Year: 2005


Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011

Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015


Effects of glucocorticoids in ventilated piglets with severe pneumonia
Source: Eur Respir J 2008; 32: 1037-1046
Year: 2008



The interconnection of severe pneumonia and sepsis
Source: Eur Respir J 2004; 24: Suppl. 48, 548s
Year: 2004

Prevention of nosocomial infections in acute respiratory failure patients
Source: Eur Respir J 2003; 22: 72S-76S
Year: 2003



Corticosteroids in severe pneumonia
Source: Eur Respir J 2008; 32: 259-264
Year: 2008



Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia
Source: Eur Respir J, 51 (3) 1702215; 10.1183/13993003.02215-2017
Year: 2018



Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients
Source: Eur Respir J 2004; 24: Suppl. 48, 548s
Year: 2004

An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011


Common pathogens in bronchial secretions of the ICU patients with nosocomial pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 405s
Year: 2001

The role of inflammatory parameters in the diagnosis and management of patients with community-acquired pneumonia
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012

The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 347s
Year: 2006

The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
Source: Eur Respir J 2009; 33: 153-159
Year: 2009